Karen Rommelfanger Publications

Karen Rommelfanger bio

PUBLISHED AND ACCEPTED ARTICLES
 
1.    Rommelfanger KS, Weinshenker D, Miller GW. Reduced MPTP Toxicity in Noradrenaline Transporter Knockout Mice. J Neurochem 91:1116-24 (2004).
 
2.    Rommelfanger KS, Edwards GL, Freeman KG, Liles LC, Weinshenker D. Norepinephrine loss produces more profound motor deficits than MPTP treatment in mice. PNAS 104: 13804-9 (2007).
    Featured in Scientific American: Fingering the Neural Perp in Parkinson’s Disease (2007).
    Featured by the Michael J. Fox Foundation Parkinson's in the News, Loss of Two Types of Neurons Triggers Parkinson's Symptoms, Study Suggests (2007).
 
3.    Rommelfanger KS, Mitrano DA, Smith Y, Weinshenker D. Light and electron microscopic localization of alpha-1 adrenergic receptor immunoreactivity in the rat striatum and ventral midbrain. Neuroscience 158: 1530-40 (2009).
 
4.    Yanpallewar SU, Fernandes K, Marathe S, Vadodaria KC, Jhaveri D, Rommelfanger K, Ladiwala U, Jha S, Muthig V, Hein L, Bartlett P, Weinshenker D, Vaidya VA. Alpha2-adrenoceptor blockade accelerates the neurogenic, neurotrophic, and behavioral effects of chronic antidepressant treatment J Neurosci 30: 1096-1109 (2010).
 
5.    Rommelfanger KS, Boshears P. Ethical Use of Neuroscience. AJOB Neuroscience, 2: 19-21 (Open Peer Commentary, 2011).
 
6.    Hadipour-Niktarash A, Rommelfanger KS, Masilamoni GJ, Smith Y, Wichmann T. Extrastriatal D2-like receptors modulate basal ganglia pathways in normal and parkinsonian monkeys 107: 1500-1512 J Neurophysiol (2011).
 
7.    Hammerschmidt T, Kummer M, Terwel D, Martinez A, Gorji A, Pape H-C, Rommelfanger KS, Schroeder J, Stoll M, Schultze J, Weinshenker D, Heneka M. Selective loss of noradrenaline exacerbates early cognitive dysfunction and synaptic deficits in APP/PS1 mice. 73:454-63 Biol Psychiatry (2013).
 
8.    Rommelfanger KS. Attitudes on Mind Over Matter. Placebos for Psychogenic Disorders 4:9-15 AJOB Neuroscience (2013).
 
9.    Rommelfanger KS. Placebo for Psychogenic Disorders. Nat Rev Neurology 9:351-56 (2013).
 
10.    Meltzer CC, Sze G, Rommelfanger KS, Kinlaw K, Banja J, Wolpe PR. Guidelines for the Ethical Use of NeuroImages in Medical Testimony: Report of a Consensus Conference Am J Neuroradiol 35: 632-7 (2014).
 
11.    Galvan A, Hu X, Rommelfanger KS, Pare JF, Smith Y, Wichmann T. Localization and Function of Dopamine Receptors in the Subthalamic Nucleus in Normal and Parkinsonian monkeys Journal of Neurophysiology 112:467-79 (2014).
 
MENTORED STUDENT PAPERS
 
1.    Trimper JB, Wolpe PR, Rommelfanger KS. When I Becomes We: Ethical implications of emerging brain-to-brain interfacing technologies. Frontiers in Neuroengineering (2014 in press).
2.    Purcell, RH and Rommelfanger KS. Internet-based brain training games, citizen scientists, and neuroprivacy of big data: Ethical issues in unprecedented virtual territories Neuron (2015 in press).
 
 
REVIEW ARTICLES/EDITORIALS
 
1.    Rommelfanger KS, Weinshenker D. Norepinephrine: The redheaded stepchild of Parkinson’s disease. Biochem Pharmacol 74: 177-190 (Invited review, 2007).
 
2.    Rommelfanger KS, Wichmann T. Extrastriatal Dopaminergic Circuits of the Basal Ganglia. Frontiers in Neuroanatomy 139: 1-17 (Invited review, 2010).
 
3.         Rommelfanger KS and Johnson LSM. What Lies Ahead for Neuroethics Scholarship and Education in Light of the Human Brain Projects. AJOB Neuroscience 6: 1-3 (2015).
 
 
BOOK CHAPTERS/ EDITED BOOKS
 
Rommelfanger KS. Place of placebo in treatment. Handbook of Neurology Volume on Functional Neurological Disorders, to be published 2015 (Elsevier).
 
Johnson, LSM and Rommelfanger KS (Eds). Routledge Handbook of Neuroethics, to be published Spring 2017 (Taylor and Francis).
 
OTHER PUBLICATIONS
 
Public Scholarship
 
1.    Rommelfanger KS. Take two placebo pills and call me in the morning. Huffington Post July 3, 2012.
 
2.    Rommelfanger KS. Placebo for psychogenic illnesses: Why "It's all in my head does and doesn't matter". Nature (Science Soapbox) July 18, 2012.
 
3.    Rommelfanger KS. Does this lab coat make me look fat? The Chronicle for Higher Education October 23, 2012.
 
Public Features
 
1.        Profiled in Brainstorm: Newsletter of the Canadian Neuroethics and Mental Health Interest Group, February    1, 2014.
 
2.        Profiled in International Neuroethics Society Newsletter, January 7, 2014.
 
3.        Interviewed about the BRAIN Initiative for Medical Ethics Advisor, July 2014 Volume 30(7), pg. 73-84.
 
4.        Interviewed for USA Today, “Light can switch bad memories to good,” August 27, 2014.
 
5.        Interviewed about preclinical detection for Medical Ethics Advisor, September 2014 Volume 30(9), pg. 97-108.
 
6.        Interviewed for Quo (Mexico City), “Cuerpo y mente unidos por un chip” (Body and mind united on a chip), November 2014, pg. 41-44.